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Oral tolerance prevents oral sensitization to dietary
antigens (Ags), including proteins and haptens, and
development of delayed-type hypersensitivity (DTH)
responses. We showed here that plasmacytoid
dendritic cells (pDCs) prevented oral T cell priming
and were responsible for systemic tolerance to
CD4+ and CD8+ T cell-mediated DTH responses in-
duced by Ag feeding. Systemic depletion of pDCs
prevented induction of tolerance by antigen feeding.
Transfer of oral Ag-loaded liver pDCs to naive recip-
ient mice induced Ag-specific suppression of CD4+
and CD8+ T cell responses to protein and hapten,
respectively. Liver is a site of oral Ag presentation,
and pDCs appeared to induce anergy or deletion of
Ag-specific T cells in the liver relatively rapidly via
a CD4+ T cell-independent mechanism. These data
demonstrate that oral tolerance relies on Ag presen-
tation by pDC to T cells and suggest that pDC could
represent a key therapeutic target for intestinal and
systemic inflammatory diseases.
INTRODUCTION
Oral tolerance is the physiologic mechanism by which the muco-
sal immune system prevents deleterious T cell-mediated de-
layed-type hypersensitivity (DTH) reactions to self and exoge-
nous dietary and environmental antigens (Ag) including food
proteins as well as small chemical molecules also known as
haptens (i.e., drugs, dyes, conservatives, and flavor enhancers)
(Dubois et al., 2005; Mowat, 2003). Studies in animal models
have documented that Ag feeding, prior to systemic immuniza-
tion with the same Ag, prevents the development of specific
T cell-mediated immunopathologies (Faria and Weiner, 2005)
and CD4+ and CD8+ T cell-mediated DTH responses to proteins
(Mowat, 2003) and haptens (Dubois et al., 2003), respectively.
Clinical studies have confirmed that systemic T cell tolerance
can be induced by Ag feeding in humans and primarily affects
T cell-mediated DTH responses but not B cell responses (Husby
et al., 1994). Along these lines, breakdown of oral tolerance to
dietary Ag or to the gut flora can cause chronic intestinal inflam-
matory diseases, as illustrated by celiac disease and inflamma-464 Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inctory bowel disease (IBD), respectively. Although CD4+ T cells
have always been thought to contribute to intestinal inflamma-
tion, emerging data indicate that in both celiac disease and
IBD, CD8+ T cells mediating DTH might initiate inflammation by
exerting cytotoxicity against epithelial cells (Hue et al., 2004;
Nancey et al., 2006).
Severalmechanismscontribute tooral tolerance includinganergy
or deletion of antigen-specific T cells and activation of regulatory
CD4+ T cells that encompass natural CD4+CD25+Foxp3+ and
antigen-specific regulatory T (Treg) cells producing the cytokines
TGF-b and/or IL-10 (Dubois et al., 2005). Although dendritic cells
(DC) likely play a role in oral tolerance induction (Viney et al.,
1998), there is as yet no direct evidence of the implication of my-
eloid or other types of DC, and the sites of oral Ag presentation by
DC remain elusive. Although orally administered Ag can be pre-
sented to T cells by DC in both Peyer’s patches (PP) and mesen-
teric lymph nodes (MLN) (Kunkel et al., 2003), oral tolerance
requires MLN (Spahn et al., 2001; Worbs et al., 2006) but not
PP (Spahn et al., 2001). Oral Ag can be captured by DCs in the
intestinal lamina propria (LP) and transported to MLN via the
mesenteric lymph (Mowat, 2003). The recent observation that
myeloid DC of both MLN and LP can convert CD4+ T cells into
Foxp3+ Treg in vitro (Coombes et al., 2007; Sun et al., 2007), or
induce IL-10-producing CD4+ Treg cells (Bilsborough et al.,
2003) might explain their suspected role in oral tolerance (Viney
et al., 1998). However, oral tolerance also involves systemic diffu-
sion of free Ag via blood. Indeed, a variable fraction of food pro-
tein entering blood vessels in the lamina propria reaches the liver
via the portal vein and disseminates systemically, intact or in the
form of polypeptides, in peripheral lymphoid organs (Swarbrick
et al., 1979). Direct evidence for a role of the liver in tolerance is
provided by the observation that portocaval anastomosis, which
prevents draining into the liver of Ags from the gut, abrogates oral
tolerance to proteins or haptens (Cantor and Dumont, 1967; Yang
et al., 1994). Along these lines, it has been shown that T cell toler-
ance in the liver and in the spleen can occur within hours after Ag
feeding (Gutgemann et al., 1998; Ju and Pohl, 2001; Li et al.,
2004), suggesting that Ag presentation by antigen-presenting
cells (APCs) outside the gut-associated lymphoid tissues
(GALT) can be involved in oral tolerance.
Plasmacytoid DC (pDC) represent an unconventional type of
APC that is typified by their ability to contribute to antiviral innate
immunity by producing type I interferon (IFN) upon activation
(Asselin-Paturel et al., 2001). They also participate in adaptive
immune responses by directing either T helper 1 (Th1) cell or.
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Plasmacytoid DC Are Essential to Oral ToleranceFigure 1. Organ Distribution of Orally Administered Hapten
(A) Immunohistochemical analysis of DNP capture in the small intestine, at various time points after DNFB gavage (initial magnification 320). Cryostat section
(5 mm) of small intestine were stained with a biotinylated DNP mAb and streptavidin peroxidase, and the reaction was developed using amino-ethyl carbazole.
(B) Peyer’s patches, spleen, MLN, liver, hepatic LN, or axillaries and inguinal LN were harvested at 2 hr after vehicle feeding (white bars) or 2 hr (hatched bars) and
24 hr (black bars) after DNFB gavage. Isolated leukocytes (105 cells/well) were cocultured for 3 days with CD8+ T cells (105 cells/well) from day 5 DNFB-sensitized
mice. Proliferation was determined by 3H-thymidine uptake during the last 8 hr of culture. Results are expressed as mean cpm ± SD of triplicate wells containing
pooled cells from four mice per group. Data are representative of one out of three independent experiments.Th2 cell development (Boonstra et al., 2003). However, pDC at
the immature state have a poor capacity to support T cell prolif-
eration (Asselin-Paturel et al., 2001) and can even suppress T cell
responses (Bilsborough et al., 2003; Martin et al., 2002). Indeed,
pDC contribute to peripheral T cell tolerance including transplan-
tation tolerance (Ochando et al., 2006), tumor escape (Munn
et al., 2004), and mucosal tolerance in an animal model of
asthma (De Heer et al., 2004). However, whether and how pDC
contribute to oral tolerance has not been previously studied.
The goal of this study was to identify the type and location of
DC that could play an essential role in oral tolerance and could
achieve efficient suppression of CD4+ and CD8+ T cell-mediated
DTH responses. To monitor oral tolerance of CD8+ T cell-medi-
ated DTH responses to a soluble Ag, we used a model of hap-
ten-specific skin DTH, induced by CD8+ CTL independently of
CD4+ T cell help (Desvignes et al., 2000). In this model, covalent
binding of the hapten to proteins generates hapten-modified self
peptides, which are presented by MHC class I molecules and
induce priming of IFNg-producing CD8+ CTL effectors mediating
contact dermatitis (Dubois et al., 2003; Kehren et al., 1999) or
colitis (Nancey et al., 2006). We also analyzed the induction of
oral tolerance in a classical model of DTH, mediated by specific
CD4+ T cells, to a more conventional dietary protein, ovalbumine
(OVA). We showed here that oral tolerance relies on pDCs, which
suppress both CD4+ and CD8+ T cell-mediated DTH responses.
RESULTS
Oral Ag Is Rapidly Captured in the Liver
and in Peripheral Lymphoid Organs
The localization and fate of oral Ag in normal mice was examined
using 2.4-dinitrofluorobenzene (DNFB) as a model Ag, as itsIbinding to self proteins allows in situ detection by staining with
a DNP-specific mAb. Kinetic immunohistochemical analysis
revealed that the hapten is detectable as early as 30 min after ga-
vage in the gut epithelium, appears by 6 hr in the intestinal lamina
propria, and disappears at 24 hr (Figure 1A). Because after local
uptake the Ag was not identifiable by immunohistochemical
analysis in lymphoid and nonlymphoid organs, we set up a func-
tional ex vivo antigen presentation assay to determine the pres-
ence of Ag-presenting cells in different organs after intragastric
administration of DNFB. To this aim, leukocytes were isolated
from MLN, spleen, liver or different lymph nodes (LN) and used
to stimulate the proliferation of CD8+ T cells from day 5 DNFB-
sensitized mice. CD8+ T cell proliferation was induced by leuko-
cytes isolated from all organs of DNFB-fed mice except the
spleen (Figure 1B). Leukocytes from MLN and inguinal or axillary
LN induced specific CD8+ T cell proliferation at 2 and 24 hr after
DNFB gavage. However, liver and hepatic LN cells were able to
induce proliferation only when isolated at 2 hr but not at 24 hr,
suggesting that the hapten rapidly disappeared from these two
sites or that Ag-loaded APC from liver and hepatic LN become
unable to stimulate CD8+ T cell proliferation. These data illustrate
that orally administered hapten rapidly diffuses to the liver and
hepatic LN and also reaches systemic LN including MLN.
Ag Delivery by Oral or Intraportal Route Prevents
CD8+ T Cell-Mediated DTH
We previously documented that oral administration of DNFB,
prior to skin sensitization with the hapten, completely prevented
the development of hapten-specific CD8+ T cells mediating con-
tact hypersensitivity (CHS) (Desvignes et al., 2000; Dubois et al.,
2003). To determine whether systemic diffusion of dietary anti-
gen via the hepatic portal venous system could contribute tommunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc. 465
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Plasmacytoid DC Are Essential to Oral ToleranceFigure 2. Hapten Delivery by Either Oral or Intraportal Routes Induces Tolerance of CD8+ T Cells Mediating CHS
(A) Hapten-specific CHS. On day7, mice were fed with 0.1% DNFB diluted in acetone and olive oil (1:10 v/v) (closed squares) or injected via the portal vein with
125 mg/kg DNBS diluted in PBS (closed circles) or with PBS alone (open circles). All mice were DNFB sensitized on day 0 and ear challenged on day 5, and CHS
response was determined by ear swelling (mm) at various times after hapten challenge. Results are expressed as mean ear swelling (mm ± SD) for five to seven
mice per group and are representative of one out of two independent experiments. *p < 0.01 PBS-injected mice compared to DNBS-injected mice.
(B) Hapten-specific CD8+ T cell response. Mice were treated and sensitized as in Figure 2A. Purified CD8+ T cells (2 3 105) harvested from inguinal and axillary
lymph nodes on day 5 after skin sensitization were restimulated in vitro for 3 days with irradiated spleen cells (53 105) either untreated or pulsed with DNBS, and
IFN-gwas titrated by ELISA in day 3 supernatants. Results are expressed as mean IFN-g production (UI/ml) ± SD of triplicate wells containing pooled CD8+ T cells
from four mice per group. Data are representative of one out of two independent experiments.CD8+ T cell tolerance, we compared the CHS response in mice
previously exposed to the Ag by gavage or by injection in the
portal vein. Control mice injected with PBS in the portal vein
developed an ear swelling response that peaked at 48 hr after
DNFB challenge (Figure 2A) and correlated with the priming of
hapten-specific interferon-g (IFN-g)-producing CD8+ T cells
(Figure 2B). Oral gavage with DNFB or intraportal injection of
DNBS (a soluble form of DNFB) were similarly efficient at inhibit-
ing the DNFB-specific CHS response (Figure 2A) and prevented
the differentiation of hapten-specific IFN-g-producing CD8+
T cells (Figure 2B). Thus, oral gavage and immunization through
the hepatic portal vein are equally efficient at inducing CD8+
T cell tolerance.
Plasmacytoid Dendritic Cells Are the Tolerogenic
CD11c+ DC of the Liver
To analyze whether hepatic DC after oral administration of Ag
had tolerogenic functions, CD11c+ cells were purified from the
liver and tested for their capacity to induce or suppress hap-
ten-specific T cell and CHS responses. CD11c+ cells account
for as much as 15%–20% of CD45+ liver leukocytes (Figure 3A)
and exhibit an immature phenotype with low expression of MHC
class II, CD80, and CD86, and a low allostimulatory potential
(data not shown), confirming previous data (Lu et al., 2001;
Watanabe et al., 2003). Unlike in vitro-generated bone marrow-
derived DCs (BMDCs), liver CD11c+ cells pulsed in vitro with
DNBS were unable to induce a CHS response when injected
subcutaneously (s.c.) into naive mice (Figure 3B). Moreover, un-
pulsed liver CD11c+ DCs delivered at the site and time of DNFB
skin sensitization completely prevented induction of the CHS
response (Figure 3C), demonstrating that liver DCs exert an
inhibitory effect.
CD11c+ liver cells contained around 50% of NK1.1+ cells that
likely correspond to NK cells expressing CD11c as well as 40%466 Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Incof CD11b NK1.1 cells and 10% of CD11b+ NK1.1 cells
(Figure 3A), both of which mostly contained DCs (Figure S1A).
These three populations of CD11c+ cells sorted on the basis of
CD11b and NK1.1 expression (Figure 3A) were compared for their
relative ability to inhibit the CHS response upon s.c. transfer at the
time of skin sensitization. The CHS response was not affected by
transfer of either CD11c+CD11b+NK1.1- or CD11c+NK1.1+ cell
subsets. In contrast, transfer of CD11c+CD11bNK1.1 cells
conferred almost complete inhibition of the CHS response
(Figure 3D) and prevented priming of hapten-specific IFN-g-pro-
ducing CD8+ T cells in skin draining LN (Figure 3E).
Interestingly, 60%–80% of CD11c+CD11bNK1.1 liver cells
expressed the plasmacytoid DC marker BST-2, as revealed by
staining with the 120G8 mAb (Figure S1B) (Asselin-Paturel
et al., 2003). Indeed, as described for pDC of lymphoid organs
(Asselin-Paturel et al., 2001, 2003; Blasius et al., 2006), liver
CD11c+120G8+ cells expressed B220, Ly6C, BST-2, Siglec-H,
and varying levels of CD8a (Figures S1B, S1C, and S3C) and pro-
duced type I IFN upon in vitro culture with influenza virus (data
not shown). pDC represented up to 30% of total CD11c+ liver
cells and were contained within the CD11c+CD11bNK1.1 sub-
population of liver DC (Figure S1C). We thus examined whether
pDC accounted for the capacity of liver CD11c+ DC to induce
hapten-specific T cell tolerance. CD11c+NK1.1CD11b leuko-
cytes were sorted into 120G8+ (pDC) and 120G8 cell subsets
and injected s.c. into naive C57Bl/6 mice at the time of skin sen-
sitization with DNFB. Adoptive transfer of FAC-sorted 120G8
cells did not affect the frequency of hapten-specific IFN-g-
producing CD8+ T cells (Figure 3E), which are effector cells of
CHS (Kehren et al., 1999). In contrast, sorted 120G8+ pDC trans-
fer decreased by 60% the frequency of hapten-specific IFN-g-
producing CD8+ T cells (Figure 3E) and completely prevented
the CHS response (Figure 3F). Thus, pDC were immunoregula-
tory and accounted for the tolerogenic property of liver DC..
Immunity
Plasmacytoid DC Are Essential to Oral TolerancepDCAreRequired for Oral Tolerance of CD8+ andCD4+ T
Cell-Mediated DTH Responses
To directly address the role of pDC in oral tolerance, pDC were
depleted in vivo using the RB6-8C5 anti-Gr1 mAb. Anti-Gr1 effi-
ciently depleted 80% of liver pDC as assessed both by evalu-
ating the remaining frequency of liver pDC by flow cytometry and
by measuring the loss of ability of MAC-sorted CD11c+ liver DC
to produce IFN-a in response to virus stimulation, a functional
property of pDC (Figures S2A and S2B). Mice injected with the
control rat mAb GL113 were tolerized by oral administration of
the hapten, whereas oral tolerance was impaired in Gr1 mAb in-
jected mice, as demonstrated by restoration of CHS (Figure 4A)
and increased IFN-g production by CD8+ T cells (Figure 4B). Be-
cause the Gr1 mAb in addition to pDC also depleted neutrophils,
eosinophils, and other Gr1+ cells, we tested whether tolerance
could be reversed by injection of another mAb targeting pDC,
i.e., the 120G8 mAb (Asselin-Paturel et al., 2003). Treatment
with 120G8 efficiently depleted pDC from the liver (Figure S2C),
MLN, and spleen (data not shown), as assessed by flow cytom-
etry with anti-BST-2 or anti-SiglecH mAbs. Tolerance to DNFB
could not be induced in 120G8-treated mice, as demonstrated
by the similar intensity of the CHS (Figure 4C) and CD8+ T cell re-
sponses (Figure 4D) in both vehicle-fed and hapten-fed mice.
Furthermore, systemic sensitization could be induced by a single
DNFB gavage (without skin painting) in 120G8 mAb-treated
mice, as evidenced by the development of a CHS response
upon ear challenge 5 days later (Figure 4E). Thus, pDC are re-
quired for induction of CD8+ T cell tolerance by oral hapten
delivery and their absence permits oral sensitization and devel-
opment of a CHS response.
To confirm whether pDC were also required for oral tolerance
to a more conventional dietary protein (ovalbumine, OVA), we
used the classical model of DTH to OVA, mediated by specific
CD4+ T cells. We showed that intragastric delivery of 20 mg of
OVA 3 times on days 13, 10, and 7 (protocol depicted on
Figure 5A) nearly completely prevented the DTH response to
OVA (80% of suppression of footpad swelling; Figure 5B). In
vivo depletion of pDC by 120G8 mAb treatment of OVA-fed
mice, prevented suppression of footpad swelling and of IFN-g
production by OVA-specific T cells, by roughly 50% (Figures
5B and 5C). Similar results were obtained in mice fed from day
14 to7 with 20 mg/ml OVA in drinking water (data not shown).
These data demonstrate that pDC also inhibit DTH responses
induced by gavage with a protein Ag.
Comparison of the Tolerogenic Potential of pDC
from Liver, MLN, and Spleen of Ag-Fed Mice
We next examined the efficacy of tolerance induction by pDC
from Ag-fed mice and asked whether it depended on their tissue
origin. Graded numbers of MAC-sorted liver pDC, isolated from
DNFB- or vehicle-fed mice (Figure S3A), were transferred into B6
recipient mice at the time of immunization with hapten-pulsed
BM-DC and tested for their ability to inhibit CD8+ T cell-mediated
CHS responses. pDC enriched from liver leukocytes of vehicle-
fed mice had a modest inhibitory effect only at the highest
dose (105). In contrast, a dose-dependent suppression of the
ear swelling response was achieved by transfer of pDC-enriched
leukocytes from DNFB-fed mice, with significant inhibition with
as few as 104 cells (Figure 6A). Importantly, transfer of 105IFAC-sorted pDC (which contained >97% pure pDC; Figures
S3B and S3C) from liver or MLN cells of hapten-fed mice were
similarly efficient to prevent in vivo priming of hapten-specific
IFN-g-producing CHS effectors, whereas T cell priming was
only moderately affected by transfer of splenic pDC either puri-
fied from vehicle- or DNFB-fed mice (Figure 6B). In addition,
pDC purified from the liver, but not spleen, efficiently suppressed
the proliferation of hapten-specific CD8+ T cells in vitro (Fig-
ure S4A). Thus, pDC from the liver and MLN, but not spleen, of
hapten-fed mice can induce T cell tolerance and suppression
of DTH responses in vivo.
Suppression of DTH Responses by Liver pDC
from Ag-Fed Mice Is Antigen Specific
To further analyze whether liver pDCs carrying oral Ag can control
CD4+ or CD8+ T cell-mediated DTH reactions in an Ag-specific
way, adoptive transfer experiments were performed. Transfer
of liver pDCs purified by FACS from OVA-fed mice suppressed
the DTH response induced by immunization with OVA-pulsed
BMDCs (Figure 6C). In contrast, liver pDCs from DNFB-fed
mice or from oxazolone (OXA)-fed animals did not modify at all
the DTH response. Likewise, analysis in the model of CD8+ T cell
mediated CHS response to DNFB, induced by immunization with
DNBS-pulsed BMDCs, revealed that only pDCs from DNFB-fed
mice could suppress skin inflammation, whereas pDCs from
mice fed with the hapten OXA or the protein Ag OVA were ineffi-
cient (Figure 6D). Similarly, only pDC from DNFB-fed animals effi-
ciently suppressed the proliferation of CD8+ T cells invitro inanAg-
specific way (Figure S4B). Together with the results described
above (Figure 5), these observations demonstrate that soon after
feeding witha protein Ag or a hapten, liver pDC exhibit the capacity
to present the oral Ag to T cells and to perform Ag-specific sup-
pression of DTH responses in vivo.
Plasmacytoid DC Induce Anergy or Deletion of
Ag-Specific T Cells in the Liver Shortly after Ag Feeding
The above results suggest that the liver constitutes a key organ
where presentation of oral Ag by pDC might induce tolerance. To
analyze the mechanism by which pDC in the liver induce toler-
ance, we analyzed the fate of Ag-specific CD8+ T cells after
DNFB feeding. To circumvent the lack of tools to directly identify
hapten-specific T cells, we developed a CHS model by transfer-
ring CD8+ T cells into T cell-deficient CD33-deficient mice. CD8+
T cells were purified from donor mice 1 or 6 days after vehicle or
DNFB gavage, and adoptively transferred into Cd33/ recipient
mice. Three weeks later, recipient mice were skin sensitized with
DNFB and tested for their capacity to initiate a CHS response
upon DNFB challenge. Recipients of CD8+ T cells isolated either
from the liver or MLN of vehicle-fed control B6 donors were able
to mount a CHS response after DNFB sensitization and chal-
lenge (Figure 7A). In contrast, adoptive transfer of CD8+ T cells
from day 6 DNFB-fed donors hardly induced any ear swelling
response in Cd33/ recipients and had a reduced capacity to
differentiate into IFN-g-secreting effector T cells upon skin sen-
sitization (Figure 7B). These results demonstrate that Ag feeding
of B6 mice induces, in MLN and liver, a massive decrease of
the number of hapten-specific T cells able to differentiate into
DTH effector cells. Importantly, this loss of Ag-reactive T cells,
revealed by an impaired capacity to differentiate into CHSmmunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc. 467
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Plasmacytoid DC Are Essential to Oral ToleranceFigure 3. Liver Plasmacytoid DC Are Tolerogenic In Vivo
(A) FACS analysis and sorting of hepatic DC subsets. Liver leukocytes were stained with anti-CD11c, anti-CD11b and anti-NK1.1. Gated CD11c+ cells (left dot
plot) were analyzed for CD11b and NK1.1 expression (right dot plot) and were FAC-sorted into three subsets: CD11c+CD11b+orNK1.1+ (R1),
CD11c+CD11b+NK1.1 (R2), and CD11c+CD11bNK1.1 (R3).
(B) Liver CD11c+ cells are unable to prime a CHS response to DNFB. Mice were immunized on day 0 by s.c. transfer of 105 BM-DC (open squares) or MAC-sorted
CD11c+ liver cells (closed squares) pulsed in vitro with DNBS. CHS was determined by ear swelling (mm ± SD of five to seven mice per group) after DNFB
challenge on day 5. *p < 0.01.
(C) Liver CD11c+ cells inhibit CHS to DNFB. Unpulsed (105) liver CD11c+ cells (closed circles) or PBS (open circles) were injected subcutaneously in naive mice at
the time and site of skin painting with DNFB. CHS was determined by ear swelling (mm ± SD of five mice per group) after DNFB challenge 5 days later. *p < 0.05.
(D–F) In vivo adoptive transfer experiments. Each subset of R1 (closed squares), R2 (open circles), and R3 (closed circles) sorted CD11c+ liver cells shown in (C)468 Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc.
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Plasmacytoid DC Are Essential to Oral Toleranceeffectors, was observed in MLN only at 6 days but not at 1 (Fig-
ure 7B) or 3 days (data not shown) after DNFB feeding. In con-
trast, the impaired capacity to differentiate into CHS effectors
occurred in the liver as early as day 1 and persisted up to day
6 after gavage. Thus, hapten feeding resulted in anergy or dele-
tion of hapten-reactive CD8+ T cells that is rapid and long lasting
in the liver but delayed in the MLN. Further, depletion of pDC
prior to hapten feeding of donor mice completely prevented
this anergy or deletion of hapten-reactive MLN CD8+ T cells
and restored their ability to differentiate into CHS effectors
when transferred into Cd33/ mice (Figure 7C). Finally, hapten
feeding of wild-type B6 or MHC class II Ab-deficient mice simi-
larly impaired the capacity of MLN CD8+ T cells to generate a
Figure 4. Antibody Depletion of pDC Prevents Induc-
tion of Oral Tolerance and Allows for Oral Priming
(A–D) Mice were injected with either anti-Gr1 RB8.6C5 mAb or
anti-BST2 120G8 mAb to deplete pDC, or with the control rat
GL113 mAb, and tested for induction of oral tolerance as
monitored by the CHS (A and C) and CD8+ T cell responses
to DNFB (B and D), as described in the Experimental Proce-
dures and in the legend of Figure 2. In (A), *p < 0.01 between
control mAb- and anti-Gr1-treated DNFB-fed mice. In (B), ***
p < 0.0001; ** p = 0.0071. Data in (A)–(D) are representative
of three reproducible experiments using five to seven mice
per group.
(E) To test for oral priming, mice were fed with DNFB or vehicle
and ear challenged 5 days later, and the ear swelling response
was determined after 48 hr (one representative experiment out
of two).
CHS response after adoptive transfer intoCd33/-
recipient mice (Figure 7D), indicating that the orally
induced anergy or deletion of Ag-specific T cells
does not involve CD4+ T cells.
Altogether, these data show that anergy or dele-
tion of T cells specific for the oral Ag occurs at early
times in the liver and later in MLN, and is mediated
by pDC independently of CD4+ T cells.
DISCUSSION
This study demonstrates that pDC presenting die-
tary Ags are responsible for induction of oral toler-
ance and immune suppression affecting both CD4+
and CD8+ T cell responses. Using models of oral
tolerance to a classical dietary protein Ag (OVA)
and to the allergenic hapten DNFB, we showed
that suppression of systemic CD4+ or CD8+
T cell-mediated DTH responses requires pDC. In-
deed, in vivo depletion of pDC using either the
Gr1 (RB6.8C5) mAb (Asselin-Paturel et al., 2001)
or the more selective BST-2 (120G8) mAb (Asselin-Paturel
et al., 2003; Blasius et al., 2006) abrogated oral tolerance and
suppression of DTH responses in both models. A single intragas-
tric hapten gavage in pDC-depleted naive mice resulted in oral
T cell priming and development of a CHS response after skin
hapten challenge. In addition, similarly to Ag feeding (Desvignes
et al., 2000), adoptive transfer of pDC from Ag-fed mice pre-
vented T cell priming and induction of DTH responses in an
Ag-specific way. The important role of pDCs in oral tolerance
is in line with the previous observation that Flt3-L treatment,
which by increasing the number of DC including pDC (Gilliet
et al., 2002), results in more efficient oral tolerance (Viney
et al., 1998).was transferred s.c. (105 cells/mouse) into naive mice at the site and time of skin sensitization with DNFB (day 0). Untransferred but DNFB skin-sensitized mice
(open squares) were used as controls. In (D) and (F), all mice were ear challenged on day 5, and CHS to DNFB was determined by ear swelling (mm ± SD of five
mice per group) at (D) various times or (F) 24 hr after DNFB challenge. *p < 0.05 between the untransferred group and the R3-transferred group. In (E), at day 5, the
frequency of hapten-specific IFN-g-spot-forming cells (SFC) in draining lymph nodes was determined by ELISPOT. Results are expressed as the mean number of
SFC per 106 CD8+ T cells ± SD of triplicate wells containing pooled CD8+ T cells from four mice per group. In (E), right panel, and (F), in an independent experiment,
CD11c+CD11bNK1.1 liver leukocytes were further sorted into 120G8+ pDC and 120G8 cells and tested for their capacity to suppress priming of (E) hapten-
specific IFN-g SFC or a (F) CHS response. Each data set is representative of two (D–F) to four (B and C) independent experiments.Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc. 469
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Plasmacytoid DC Are Essential to Oral ToleranceAnergy or deletion of Ag-specific T cells and active suppres-
sion by regulatory T cells are the two major mechanisms involved
in orally induced T cell tolerance (Dubois et al., 2005; Mowat,
2003). We provide in vivo evidence that the main mechanism by
which pDCs contribute to oral tolerance is by inducing anergy
and/or deletion of nearly 70%–80% of Ag-specific T cells. In-
deed, Ag feeding impaired the capacity of Ag-reactive T cells
from liver and MLN of B6 donor mice to differentiate into DTH ef-
fectors upon adoptive transfer into T cell-deficientCd33/mice,
and this effect was completely prevented by pDC depletion of do-
nor mice. Interestingly, pDC-mediated functional inactivation of
Ag-specific T cells did not require CD4+ T cells indicating that
the mechanism by which pDCs reduces the size of the circulating
pool of Ag-specific T cells is independent of their capacity to trig-
ger CD4+ Treg cell differentiation. It can be postulated that pDCs,
which harbor low amounts of MHC peptide complexes and cos-
timulatory molecules (Asselin-Paturel et al., 2001), make short or
weak interactions with naive T cells. Similarly to conventional
immature DC (Gett et al., 2003), pDCs may thus induce abortive
proliferation and/or desensitization of Ag-specific T cells that
fail to differentiate into CD4+ or CD8+ effector or memory T cells
and die by neglect. The newly recognized cytotoxic potential of
pDCs and the production of molecules favoring T cell apoptosis,
like IDO (Sharma et al., 2007) and TNF-a (Kingham et al., 2007),
could explain their suppressive function.
Due to its unique vascular supply, the liver receives via the
portal vein a majority of soluble Ag from the gut lamina propria
and has long been recognized as an immune-privileged organ
that contributes to oral tolerance. Previous studies reported
that creating a portocaval shunt to bypass the liver and prevent
Ag transport from the gut to the liver via the portal vein, abrogates
oral tolerance in response to either protein or hapten (Cantor and
Dumont, 1967; Yang et al., 1994), Ag known to induce CD4+ and
CD8+ T cell-mediated DTH. More recent studies using orthotopic
Figure 5. Antibody-Mediated Depletion of pDC Affects Oral
Tolerance to Protein Antigens
(A) Mice were injected or not with 120G8 mAb and were fed three
times either with PBS or 20 mg of OVA as depicted in the flow charts,
where # indicates the days of 120G8 mAb injections. Seven days after
the last gavage, all mice were immunized by subcutaneous injection of
OVA in PBS and CFA emulsion and challenged 1 week later with ag-
gregated OVA injected in the footpad.
(B and C) Tolerance induction was analyzed by measurement of the
DTH reaction 24 hr after challenge (mean ear swelling ± SD of five
mice per group) and (C) OVA-specific T cell IFN-g production by
spleen cells collected 48 hr after challenge and restimulated in vitro
with 1 mg/ml OVA (mean UI/ml ± of triplicate wells). *** p = 0.001;
** p = 0.0018.
liver transplants from OVA-fed donors documented that
the liver within hours after gavage is sufficient to transfer
oral tolerance and prevent systemic DTH to OVA and
that this effect could be reproduced by transfer of liver
nonparenchymal cells (Li et al., 2004). The possible impor-
tance of the liver as an inductive site of oral tolerance is fur-
ther supported by our present data showing that the liver is
highly enriched with pDC endowed with a tolerogenic po-
tential, and is a site where pDCs induce anergy or deletion
of Ag-specific T cells early after Ag feeding. pDCs, which account
for up to 30% of liver CD11c+ cells, represented the only DC sub-
set of the liver able to suppress a CHS response by preventing
in vivo priming of hapten-specific IFN-g-producing CD8+ effec-
tors, when transferred at the time and site of hapten sensitization.
Although oral hapten rapidly distributes from the gut lamina prop-
ria to the liver as well as to the GALT and systemic lymphoid
organs, anergy or deletion of Ag-reactive T cells is detected by
day 1 in the liver and only several days later in MLN, suggesting
that the very early CD4+ T cell-independent phase of oral toler-
ance to haptens is initiated by the Ag diffusion through the hem-
atic route rather than by Ag transport into the draining MLN. Fur-
thermore, we document that T cell tolerance and ability to prevent
CHS to DNFB is achieved equally well by oral and intraportal
antigen delivery.
pDCs might also exert their suppressive function in lymphoid
organs during induction of oral tolerance. In this respect, pDCs
harvested from MLN and liver of hapten-fed mice have the
same efficacy to prevent hapten-specific CD8+ T cell priming,
if transferred in similar numbers into recipient mice, indicating
that, on a per cell basis, they share similar tolerogenic properties,
although their in vivo tolerogenic potential could be conditioned
in vivo by the local microenvironment (Bilsborough et al., 2003;
Contractor et al., 2007). The fact that pDC from spleen of
Ag-fed mice were weakly suppressive upon in vivo transfer
may relate to the limited amount of oral Ag reaching the spleen,
inasmuch as they could suppress hapten-specific CD8+ T cells
when pulsed in vitro with the Ag.
Although our study highlights an unanticipated and essential
role of pDCs in the rapid and efficient anergy or deletion of
T cells specific to orally administrated Ag, we demonstrated
earlier that oral tolerance to DNFB also critically depends on
CD4+ regulatory T cells (Desvignes et al., 2000; Dubois et al.,
2003). This strongly supports the idea that oral tolerance involves470 Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc.
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Plasmacytoid DC Are Essential to Oral ToleranceFigure 6. pDC from Liver or MLN of Ag-Fed mice Efficiently Suppress DTH Responses in an Antigen-Specific Fashion
(A) DNBS-pulsed BMDCs (105) were transferred s.c. into naive mice in the presence or absence of graded numbers of pDCs (102–105) purified by MACS from the
liver of vehicle- or DNFB-fed mice. All mice were ear challenged with DNFB at day 5, and CHS to DNFB was determined by ear swelling 24 hr later. Data are
expressed as mean ear swelling (mm ± SD) and are representative of one out of two experiments with four mice per group. ***p < 0.0005 between recipients
of 105 or 104 liver pDC from DNFB-fed donors and control mice that did not receive pDC.
(B) DNBS-pulsed BM-DC (105) were injected s.c. into naive mice, either alone or together with 105 MAC-sorted pDC from liver or spleen of mice that received
DNFB or vehicle by gavage 18 hr before. In an independent experiment, pDC were purified from the liver or MLN of DNFB-fed mice by FACS and similarly trans-
ferred into naive mice. At day 5 after DC transfer, the frequency of IFN-g-secreting T cells was determined by an ELISPOT in skin-draining lymph nodes. Results
are expressed as the mean number of IFN-g SFC per 106 T cells ± SD of triplicate wells containing pooled lymph node cells from three mice per group.
(C and D) OVA-pulsed BM-DC (105) (C) or DNBS-pulsed BM-DC (D) were injected s.c. alone or together with 105 liver pDC FACS purified from mice that were fed
18 hr earlier with either DNFB, OXA, or OVA. Five days after immunization, recipients of DNBS-pulsed BM-DC were ear challenged with DNFB, and the ear swell-
ing response was determined after 48 hr (C) *** p = 0.0002. All mice that received OVA-pulsed BM-DC were challenged with aggregated OVA in the footpad 7 days
after immunization, and the DTH response, as measured by footpad swelling, was determined after 48 hr (D) * p = 0.03. These data are representative of two
independent experiments.two sequential and complementary steps with distinct underlying
mechanisms. The initial ‘‘mucosal’’ phase of oral tolerance is
induced shortly after Ag penetration through the gut epithelium
and consists of pDC-mediated deletion or inactivation of a high
proportion of Ag-specific T cells, an event that is independent
of regulatory CD4+ T cells (this study). In parallel, oral Ag pro-
motes activation and/or differentiation of CD4+ Treg cells (Thor-
stenson and Khoruts, 2001; Zhang et al., 2001) with increased
suppressive functions (Dubois et al., 2003). The subsequent
‘‘systemic’’ phase of oral tolerance operates in lymphoid organsIupon systemic immunization with the same Ag and consists
in the complete suppression of specific T cell priming mediated
by CD4+ Treg cells (Desvignes et al., 2000). These include
CD4+CD25+foxp3+ T cells, which control Ag-specific CD4+ and
CD8+ T cell responses (Sakaguchi, 2004). That oral tolerance is
abrogated by CD4+ T cell depletion at the time of systemic
immunization with the same Ag (Desvignes et al., 2000; Dubois
et al., 2003) supports that Treg cells induced or activated by
Ag feeding (Thorstenson and Khoruts, 2001; Zhang et al., 2001)
prevent systemic priming of Ag-reactive T cells that havemmunity 29, 464–475, September 19, 2008 ª2008 Elsevier Inc. 471
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Plasmacytoid DC Are Essential to Oral ToleranceFigure 7. pDC Are Required for Orally Induced Functional Deletion of Hapten-Specific CD8+ T Cells
(A–D) On day 0, 8–10 C57BL/6 or (D) MHC class II-deficient donor mice were fed with either DNFB or vehicle as control, and sacrificed 1 (B) or 6 (A–D) days later for
isolation of CD8+ T cells. CD8+ T cells (33 105, A and B, or 2.53 106, C and D) purified from the (A and B) liver or (A–D) MLN were transferred intravenously into
CD33-deficient recipient mice, that were sensitized 3 weeks later by skin painting with DNFB. Five days after sensitization, all mice were ear challenged with DNFB
and the (A) CHS response of individual, and (B–D) the frequency of hapten-specific IFN-g SFC in pooled skin draining lymph nodes (mean values of SFC ± SD of
triplicate wells) were determined.
(C) pDC were depleted in donor mice by injection of the 120G8 mAb at days 1, 0 (day of feeding), +2, and +5. Results are representative of one out two inde-
pendent experiments using five to eight Cd33/ recipients per group. Data of Figure 7B represent mean values of SFC ± SD of triplicate wells, containing CD8+
T cells pooled from five recipients. Statistics are indicated as p values in the figures.escaped anergy or deletion or may have recently emigrated from
the thymus.
Recent studies using elegant approaches of surgical ablation
of MLN as well as leukocyte sequestration in secondary lym-
phoid organs, provided convincing evidence that MLN were es-472 Immunity 29, 464–475, September 19, 2008 ª2008 Elsevier Incsential for oral tolerance in a model of CD4+ T cell-mediated DTH
response (Worbs et al., 2006). Thus, it is tempting to speculate
that MLN and liver may play complementary roles with a
division of labor with different temporal requirements to achieve
efficient oral tolerance. On the one hand, the liver due to its.
Immunity
Plasmacytoid DC Are Essential to Oral Toleranceanatomical characteristics, and the constant blood flow is the
first site exposed to large quantities of oral Ag in soluble form
and pDC enriched in this organ cause rapid and efficient deletion
of oral Ag-specific T cells (this study) constantly trafficking from
the blood. This is consistent with the observation that the liver
constitutes a privileged site for apoptosis of both CD8+ T cells
(Crispe, 2003) and CD4+ T cells (Watanabe et al., 2003). On the
other hand, MLN which collects via lymph intestinal Ags loaded
onto myeloid DC emigrating from lamina propria might constitute
the preferential site of activation/differentiation of regulatory
T cells specific for dietary Ag (Thorstenson and Khoruts, 2001;
Zhang et al., 2001). In this respect, myeloid CD103+ DC from
the MLN have the potential to drive the differentiation of func-
tional Foxp3+ Treg in vitro in the presence of retinoic acid and
TGF-b (Coombes et al., 2007), although the role of CD103+ DC
in oral tolerance remains to be formally demonstrated.
Our data clearly demonstrate that pDC perform efficient CD4+
and CD8+ T cell tolerance to orally administered haptens and
proteins. The notion that pDCs may control the emergence of
food allergy, drug-induced allergic DTH reactions, as well as
intestinal inflammatory diseases, and also favor transplantation
tolerance opens up new avenues for the development of thera-
peutic approaches targeting pDC.
EXPERIMENTAL PROCEDURES
Mice
Female C57BL/6 mice (2–4 months old) were purchased from Charles River
Laboratories (L’Arbresle, France). MHC-class II (H2-Ab/)-deficient mice
were kindly provided by D.Mathis and C. Benoist, and CD33/ mice were ob-
tained from M. Malissen. These mice were bred as homozygotes at the insti-
tute’s animal facility (Plateau de Biologie Expe´rimentale de la Souris, PBES,
Ecole Normale Supe´rieure de Lyon) under specific pathogen-free conditions.
All experiments have been approved by the ‘‘Comite´ regional d’e´thique pour
l’expe´rimentation animale’’ (CREEA) and were performed according to institu-
tional guidelines.
Contact Hypersensitivity (CHS) to DNFB
Mice were sensitized epicutaneously on abdominal skin with 0.5% DNFB
(Sigma, St. Quentin Fallavier, France) diluted in acetone-olive oil (4:1, v/v)
and ear-challenged 5 days later with 0.15% DNFB. CHS was determined by
the mouse ear swelling test as previously described (Dubois et al., 2003).
Ear swelling in unsensitized but ear challenged mice was usually <20 mm. In
some experiments (tolerance induced by the portal vein), mice were sensitized
on the dorsal skin with 0.2% of DNFB. CHS was also induced by s.c. injection
of BM-DC (105 cells) pulsed with 1.6 mM of DNBS.
Delayed Type Hypersensitivity (DTH) to OVA
Mice were immunized subcutaneously with 50 mg OVA (Seikagaku corpora-
tion, Tokyo, Japan) in 50 ml PBS/CFA emulsion, or 105 OVA-pulsed BM-DC,
and were challenged 7 days later by s.c. injection of 250 mg aggregated
OVA in 30 ml of PBS in the left hind footpad. The right footpad received PBS
as control. OVA-specific DTH was determined by footpad swelling at various
times after challenge, as described (Krasteva et al., 1998).
Tolerance Induction by Intragastric or Intraportal Antigen Delivery
Oral tolerance to DNFB was induced by intragastric administration of 0.1%
DNFB (300 ml) in acetone/olive oil (1/10, v/v) 7 days before skin sensitization
with DNFB, as described (Desvignes et al., 2000). For induction of tolerance
to OVA, mice were fed three times 20 mg of OVA (grade II, Sigma-Aldrich) in
200ml PBS by gavageondays13,10,and7beforeOVA/CFA immunization.
Tolerance via the portal route was induced by injection of 125 mg/kg of
DNBS (Sigma) in 100 ml of PBS into the portal vein of mice under isoflurane
anesthesia. For depletion of pDC, mice received multiple injections (200 ml)Iof either of anti-Gr1 antibody (clone RB6-8C5) as 1/5 dilution of ascitic fluid
in PBS, or 0.5 mg of purified rat IgG anti-BST-2 mAb (clone 120G8) (Asselin-
Paturel et al., 2003).
Isolation of Liver, Spleen, and MLN Leucocytes
Leucocytes were isolated from liver, MLN, and spleen by enzymatic digestion
at 37C for 30 min using collagenase type IA (1 mg/ml) and DNase I (0.1 mg/ml)
(each from Sigma, St Quentin Fallavier, France). Liver (Lian et al., 2003) leuko-
cytes were separated from contaminating hepatocytes by centrifugation over
a 40%–80% Percoll gradient (Percoll, density 1,130, Amersham Biosciences)
(Lian et al., 2003).
Flow Cytometry Analysis
Phenotypic studies were conducted by direct immunofluorescence staining
using the following Ab panel from Becton Dickinson (Le Pont de Claix, France):
biotinylated or phycoerythrin (PE)-conjugated hamster anti-mouse CD11c
(clone HL3), FITC, or PE-Cy5.5-conjugated rat anti-mouse CD11b (clone
M1/70), PE-conjugated rat anti-mouse CD8a (clone 53-6.7), PE-conjugated
mouse anti mouse NK1.1 (clone PK136). We also used Alexa488-conjugated
rat anti mouse pDCs (clone 120G8) (Asselin-Paturel et al., 2003). Fluorescence
was measured with a FACS can equipped with CellQuest software (Becton
Dickinson, Mountain View, CA).
Purification of CD11c+ DC Subsets
DC were enriched from liver leukocytes by magnetic sorting using anti-CD11c-
coated microbeads (Miltenyi Biotec, France). This routinely yielded to approx-
imately 90% pure CD11c+ cells. DC subsets were isolated by FACS (FACStar
cell sorter, BD Biosciences) using biotin-conjugated anti-CD11c mAb and
APC-conjugated streptavidin, PE-Cy5.5-conjugated anti-CD11b, PE-conju-
gated anti-NK1.1, and Alexa488-conjugated 120G8. Several subsets, includ-
ing CD11c+ CD11b+ NK1.1, CD11c+ CD11b NK1.1, CD11c+ CD11b+or
NK1.1+ cells, CD11c+ CD11b NK1.1 120G8 (pDC depleted), and CD11c+
CD11b NK1.1 120G8+ (sorted pDC) (Figure 3E), were obtained with a purity
>97%. Alternatively, pDC were enriched from the liver, MLN, or spleen by
MACS using mPDCA1-coated microbeads and MS columns (Miltenyi Biotec).
This yielded 70%–80% pure pDC expressing CD11c and BST-2 (Figure S3A).
For certain experiments, >97% pure CD11cintBST-2+ pDC were obtained by
FACS (Figure S3B).
Ag-Specific T Cell Responses
The presence of hapten-specific T cells was determined by proliferation assay,
IFN-g ELISA, and IFN-g ELISPOT after in vitro restimulation of either MAC-
sorted CD8+ T cells or total LN cells with hapten-pulsed spleen cells or
BM-DC as described (Dubois et al., 2003; Le Borgne et al., 2006). For ex
vivo antigen presentation assay, 105 leukocytes isolated from either DNFB
or vehicle-fed mice were used as APC and cocultured with hapten-specific
CD8+ T cells. Hapten-specific T cell proliferation was determined on day 3 of
culture by 3H-thymidine incorporation (1 mCi/well) during the last 8 hr of culture.
OVA-specific T cell responses were determined by measuring IFN-g produc-
tion by spleen cells stimulated for 48 hr in vitro with 1 mg/ml OVA.
Statistical Analysis
Statistics were performed using the Student’s t test. P values <0.05 were
considered to be statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be found with this article online
at http://www.immunity.com/cgi/content/full/29/3/464/DC1/.
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